Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.

Every year has its “it” term.In 2025, the crown belonged to AI, and rightfully so. AI dominated the headlines, flooded the USPTO’s dockets, ...

Currently, some Starlink subscribers, including RV drivers, manually install Starlink dishes on their vehicles to connect to ...

Patent covers novel approach for training AI systems and classifying cells in oncologic histopathological tissue diagnosticsHamburg, Germany –  10 December 2025 – Mindpeak, a global pioneer in ...

Electronic gifts are very popular, and in recent years, retailers have been offering significant discounts on smartphones, ...

Artificial intelligence patenting in insurance is becoming a high-stakes, highly concentrated race dominated by a handful of U.S. carriers.

In follow up to the August 4, 2025 guidance and September 26, 2025 In re Desjardins decision, the USPTO recently took another significant step ...

GM has filed a trademark application for uMan Robot Assist, a name intended for use with collaborative robots and The General ...

Researchers from ETH Zurich have succeeded in introducing large quantities of unnatural amino acids into bacteria, enabling ...

Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...

On Day 8 of the trial, France explained his reasoning for resisting permanent charters to teams as the plaintiffs wrapped up their case.

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...